Not applicableStudy completedNCT01559636What this trial is testingDiarrhea and Bivalent Oral Polio Vaccine ImmunityWho this might be right forSeroimmunityDiarrheaPolio Centers for Disease Control and Prevention 699
Large-scale testing (Phase 3)Study completedNCT05831189What this trial is testingA Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile InfectionWho this might be right forClostridium Difficile Infection Recurrence Ferring Pharmaceuticals 41
Early research (Phase 1)Study completedNCT01509846What this trial is testingSafety Study of Inactivated Shigella Whole Cell Vaccine in AdultsWho this might be right forShigellosis PATH 82
Large-scale testing (Phase 3)Active Not RecruitingNCT06838195What this trial is testingClinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate VaccineWho this might be right forDysenteryDysentery, Shigella Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 8,000
Testing effectiveness (Phase 2)WithdrawnNCT01077245What this trial is testingSafety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile InfectionsWho this might be right forClostridium Difficile Infection Osel, Inc.
Post-approval studies (Phase 4)UnknownNCT02414399What this trial is testingAzithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan ChildrenWho this might be right forPneumoniaDiarrheaMalaria+3 more University of Washington 1,400
Testing effectiveness (Phase 2)Study completedNCT00382304What this trial is testingThe Absorption of GT267-004 in Patients With Clostridium Difficile-Associated DiarrheaWho this might be right forPseudomembranous ColitisClostridium Difficile DiarrheaAntibiotic-Associated Diarrhea Genzyme, a Sanofi Company 24
Testing effectiveness (Phase 2)Study completedNCT00485134What this trial is testingShigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of ProtectionWho this might be right forShigellosis U.S. Army Medical Research and Development Command 113
Large-scale testing (Phase 3)Ended earlyNCT01226992What this trial is testingOral Vancomycin Followed by Fecal Transplant Versus Tapering Oral VancomycinWho this might be right forRecurrent Clostridium Difficile InfectionLaboratory Confirmed Clostridium Difficile Infection University Health Network, Toronto 81
Early research (Phase 1)Study completedNCT02034500What this trial is testingEvaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy AdultsWho this might be right forShigellosis GSK Vaccines Institute For Global Health S.r.l. 52
Post-approval studies (Phase 4)Study completedNCT04192487What this trial is testingEffects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious DiarrheaWho this might be right forAcquired Immunodeficiency SyndromeHealthy VolunteersHIV/AIDS+2 more Napo Pharmaceuticals, Inc. 17
Early research (Phase 1)Study completedNCT01382095What this trial is testingSafety Study of Recombinant Vaccine to Prevent ETEC DiarrheaWho this might be right forEscherichia Coli Infection U.S. Army Medical Research and Development Command 40
Not applicableUnknownNCT03778125What this trial is testingMultidrug Resistant Shigella Infection in BangladeshWho this might be right forDiarrheaShigella University of Virginia 2,000
Not applicableUnknownNCT05225493What this trial is testingHIV Indicator Diseases in Hospital and Primary CareWho this might be right forHIV InfectionsPrimary Health CareAcquired Immunodeficiency Syndrome+15 more Erasmus Medical Center 1,500
Testing effectiveness (Phase 2)Study completedNCT01085591What this trial is testingStudy of CB-183,315 in Participants With Clostridium Difficile InfectionWho this might be right forClostridium Difficile InfectionDiarrhea Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 210
Large-scale testing (Phase 3)Study completedNCT00368316What this trial is testingSafety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in IsraelWho this might be right forShigellosis Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 2,799
Testing effectiveness (Phase 2)Study completedNCT04056117What this trial is testingDetermine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan InfantsWho this might be right forShigellosis LimmaTech Biologics AG 597
Early research (Phase 1)Study completedNCT04992520What this trial is testingControlled Human Infection Model Challenge/RechallengeWho this might be right forShigellosis PATH 46
Testing effectiveness (Phase 2)WithdrawnNCT03038243What this trial is testingSafety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in AdultsWho this might be right forShigella Sonnei Dysenteries PATH
Early research (Phase 1)Study completedNCT01369927What this trial is testingShigella Sonnel O-SPC/rBRU Conjugate VaccineWho this might be right forImmunogenicityShigellosis Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 60